Amarantus Bioscience Holdings Inc (AMBS)

[joboggi]

ESS is just brilliant. Yes there has been trouble around this asset but not because the asset doesn't work. Rather the trials were mismanaged. What does this create? Opportunity! And Gerald ceased it- He recently finalized the acquisition and managed to do this for pennies on the dollar. With trials slated to start in either Q3 or Q4 look to see a steady update on how the effectiveness of ESS is performing. If it is close to what its potential is then we will see in my opinion national attention.


This is the only paragraph that is close to being accurate. However GC seized the opportunity, he did not ceased it.

And it only takes one, so this is it, however, the company needs cash so they may well be taken to the shark tank and eaten. We will see.